LSA
NVAX icon

Leonteq Securities AG’s Novavax NVAX Stock Holding History

Leonteq Securities AG’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,000
Closed -$1.08M – 1331
2022
Q2 		$1.08M Buy
21,000
+1,000
+5% +$51.8K 0.04% 277
2022
Q1 		$1.47M Buy
+20,000
New +$1.78M 0.05% 235

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Leonteq Securities AG's NVAX Position: Q2 2026 in Review

Leonteq Securities AG reduced its Novavax (NVAX) stake by 25% in Q2 2026, selling an estimated $47.9K and leaving 16,464 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #620.

Leonteq Securities AG first reported a position in NVAX in Q4 2020 and has held it in 23 quarters since. The position peaked at $11.9M in Q4 2021. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Leonteq Securities AG held 16,464 shares of Novavax worth $155K as of Q2 2026.
  • Leonteq Securities AG sold 5,351 Novavax shares in Q2 2026, an estimated $47.9K.
  • Novavax made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #620 holding.
  • Leonteq Securities AG first reported a position in Novavax in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Novavax position peaked at $11.9M in Q4 2021.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.